Vycor Medical, Inc. (VYCO)
Vycor Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Boca Raton, FL, US. The stock last traded at $0.07, up 0.00% on the session, giving a market capitalisation of $2.3M. On trailing twelve-month figures it carries a trailing P/E of -172.50, a net margin of -0.7%. Its beta of -0.52 implies it has historically moved less than the broad market.
Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.
Vycor Medical, Inc. is most often compared with the following Healthcare names: